- News from July, 2012
Neurodyn Inc., a Prince Edward Island company developing early treatments for neurodegenerative diseases, announced the purchase of NeuroQuest Inc., a Halifax-based drug development company. The acquisition creates the largest neurology-focused company in Atlantic Canada by substantially increasing the company's core strengths in drug development in the neurological disease space and commercialization management.
In an energized event that resembled speed dating, six growing Nova Scotia businesses met with researchers from the Applied Human Nutrition program at Mount Saint Vincent University (The Mount), all vying for the perfect business-research match-up.
“Businesses are not always aware of the opportunities they have through universities to test products or strategies – we’d like to change that,” says Gina Funicelli, Director of The Mount’s Industry Liaison Office (ILO).
ILO Administrator Tanya Moxley used a stopwatch to time the three-minute pitches as local businesses wooed researchers with their growth and innovation potential. Businesses also promoted current products and services, from Nova Scotia cranberry juice to dietary consultation. Researchers from The Mount, Acadia, SMU, and Holland College also showcased their services, projects and ideas.
Springboard Atlantic would like to congratulate Dalhousie University on the recent announcement of its worldwide licensing agreement with Ototronix, LLC of Houston, TX for a new technology that treats conductive hearing loss and miniaturizes the power source for a hearing device.
This project originally received funding from an institution-led AIF project, as well as Springboard support. In 2009, Dr. Brown was awarded Proof of Concept funding to improve the imaging and diagnostic capabilities, as well as the intervention and monitoring of ear disorders.
Meet Brian Lowe, entrepreneur in residence.
Innovative community pharmacy collaborative research project gets industry backing